Neovasc Stock Price

-0.31 (-13.25%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Neovasc Inc NVCN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.31 -13.25% 2.03 20:00:00
Close Price Low Price High Price Open Price Previous Close
2.03 1.90 2.09 1.93 2.34
Bid Price Ask Price Spread News
2.01 2.22 0.21 - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
4,135 1,419,992 $ 1.98 $ 2,811,862 289,468 1.21 - 11.49
Last Trade Time Type Quantity Stock Price Currency
19:52:34 1 $ 2.07 USD

Neovasc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 45.97M 22.65M 6.19M $ 2.09M $ - -394.79 0.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Neovasc News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical NVCN Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week2.592.601.902.43373,372-0.56-21.62%
1 Month2.102.661.902.39358,842-0.07-3.33%
3 Months2.643.081.902.31359,314-0.61-23.11%
6 Months2.443.491.902.42319,370-0.41-16.8%
1 Year3.6711.491.213.26362,229-1.64-44.69%
3 Years149.00168.000.3726.1710,786,631-146.97-98.64%
5 Years540.00574.000.37215.857,018,785-537.97-99.62%

Neovasc Description

Neovasc Inc is a specialty medical device company. The company develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products include the Tiara for the transcatheter treatment of mitral valve disease and the Neovasc Reducer for the treatment of refractory angina. Neovasc is developing the Tiara for the treatment of mitral valve disease.

Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.